Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2000 2
2001 4
2002 4
2003 4
2004 10
2005 5
2006 5
2007 9
2008 2
2009 10
2010 12
2011 12
2012 8
2013 20
2014 23
2015 19
2016 24
2017 23
2018 19
2019 21
2020 32
2021 40
2022 31
2023 39
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Results by year

Filters applied: . Clear all
Page 1
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Ruëff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Kimball AB, et al. Among authors: passeron t. Lancet. 2023 Mar 4;401(10378):747-761. doi: 10.1016/S0140-6736(23)00022-3. Epub 2023 Feb 3. Lancet. 2023. PMID: 36746171 Clinical Trial.
Melasma, a photoaging disorder.
Passeron T, Picardo M. Passeron T, et al. Pigment Cell Melanoma Res. 2018 Jul;31(4):461-465. doi: 10.1111/pcmr.12684. Epub 2018 Jan 12. Pigment Cell Melanoma Res. 2018. PMID: 29285880 Review.
The skin aging exposome.
Krutmann J, Bouloc A, Sore G, Bernard BA, Passeron T. Krutmann J, et al. Among authors: passeron t. J Dermatol Sci. 2017 Mar;85(3):152-161. doi: 10.1016/j.jdermsci.2016.09.015. Epub 2016 Sep 28. J Dermatol Sci. 2017. PMID: 27720464 Free article. Review.
Sunscreen photoprotection and vitamin D status.
Passeron T, Bouillon R, Callender V, Cestari T, Diepgen TL, Green AC, van der Pols JC, Bernard BA, Ly F, Bernerd F, Marrot L, Nielsen M, Verschoore M, Jablonski NG, Young AR. Passeron T, et al. Br J Dermatol. 2019 Nov;181(5):916-931. doi: 10.1111/bjd.17992. Epub 2019 Jul 15. Br J Dermatol. 2019. PMID: 31069788 Free PMC article. Review.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. Among authors: passeron t. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792
Melasma: The need for tailored photoprotection to improve clinical outcomes.
Morgado-Carrasco D, Piquero-Casals J, Granger C, Trullàs C, Passeron T. Morgado-Carrasco D, et al. Among authors: passeron t. Photodermatol Photoimmunol Photomed. 2022 Nov;38(6):515-521. doi: 10.1111/phpp.12783. Epub 2022 Mar 8. Photodermatol Photoimmunol Photomed. 2022. PMID: 35229368 Free PMC article. Review.
Editorial: Immunology of Vitiligo.
Seneschal J, Harris JE, Le Poole IC, Passeron T, Speeckaert R, Boniface K. Seneschal J, et al. Among authors: passeron t. Front Immunol. 2021 Jun 24;12:711080. doi: 10.3389/fimmu.2021.711080. eCollection 2021. Front Immunol. 2021. PMID: 34249018 Free PMC article. No abstract available.
320 results